Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Syra Health Corp. (SYRA : OTC)

• Company Description    Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. Number of Employees: 89

• Price / Volume Information    Yesterday's Closing Price: $0.49 Daily Weekly Monthly 20 Day Moving Average: 24,595 shares Shares Outstanding: 13.84 (millions) Market Capitalization: $6.82 (millions) Beta: 3.10 52 Week High: $0.70 52 Week Low: $0.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 15.58% 9.94% 12 Week 447.22% 405.88% Year To Date 475.35% 361.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1119 Keystone Way N. 201 - Carmel,IN 46032 USA ph: 46-3345-8950 fax: - christined@syrahealth.com http://www.syrahealth.com

• General Corporate Information    Officers Gregory R Alexander - Chief Executive Officer Priya Prasad - Chief Financial Officer and Chief Operating Office Vijayapal R. Reddy - Director Ketan Paranjape - Director Avutu S. Reddy - Director Peer Information Syra Health Corp. (HLIS) Syra Health Corp. (AZTA) Syra Health Corp. (APYI) Syra Health Corp. (RNVA) Syra Health Corp. (HMSY) Syra Health Corp. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 87168W203 SIC: 7361 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/11/26 Share - Related Items Shares Outstanding: 13.84 Most Recent Split Date: (:1) Beta: 3.10 Market Capitalization: $6.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.88 Price/Cash Flow: - Price / Sales: 0.89 EPS Growth vs. Year Ago Period: 150.00% vs. Previous Quarter: 300.00% Sales Growth vs. Year Ago Period: 22.34% vs. Previous Quarter: 31.08% ROE 03/31/26 - -8.10 12/31/25 - -39.09 09/30/25 - -50.85 ROA 03/31/26 - -5.47 12/31/25 - -27.12 09/30/25 - -35.82 Current Ratio 03/31/26 - 2.48 12/31/25 - 4.06 09/30/25 - 3.05 Quick Ratio 03/31/26 - 2.48 12/31/25 - 4.06 09/30/25 - 3.05 Operating Margin 03/31/26 - -2.41 12/31/25 - -12.41 09/30/25 - -16.90 Net Margin 03/31/26 - -2.41 12/31/25 - -12.41 09/30/25 - -16.90 Pre-Tax Margin 03/31/26 - -2.39 12/31/25 - -12.40 09/30/25 - -16.89 Book Value 03/31/26 - 0.17 12/31/25 - 0.19 09/30/25 - 0.19 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©